Glycemic variability (GV), defined as an integral component of glucose homoeostasis, is
emerging as an important metric to consider when assessing glycemic control in clinical …

Cardiovascular disease (CVD) is highly prevalent in patients with type 1 diabetes (T1D) and
a major cause of mortality. CVD arises earlier in life in T1D patients and is responsible for a …

The introduction of continuous glucose monitoring inaugurated a new era in clinical practice
by shifting the characterization of glycemic control from HbA1c to novel metrics. The one that …

Aims/hypothesis Suboptimal subjective sleep quality is very common in adults with type 1
diabetes. Reducing glycaemic variability is a key objective in this population. To date, no …

This study aimed to investigate the relationship between red cell distribution width (RDW)
and erythrocyte osmotic stability in non‐diabetic and diabetic individuals in both sexes. The …

Background We investigate the association between mean HbA1c, HbA1c variability, and all-
cause mortality and diabetes-related macrovascular complications in patients with diabetes …

The COVID‐19 pandemic has highlighted the vulnerability of people with diabetes mellitus
(DM) to respiratory viral infections. Despite the short history of COVID‐19, various studies …

The major cause of morbidity and often premature mortality in people with type I diabetes
(T1D) is cardiovascular disease owing to accelerated atherosclerosis. We review …

Cardiovascular disease (CV) is a common complication of type 1 diabetes (T1D) and a
leading cause of death. T1D patients are more likely to develop CV disease (CVD) early in …

Objectives Recently, numerous studies have renewed attention to the hematologic profile in
the early identification of diabetic inflammation and complications. The objective of this study …